Capital Bank & Trust’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Capital Bank & Trust's NVO Position: Q3 2021 in Review
Capital Bank & Trust sold out of Novo Nordisk (NVO) in Q3 2021, closing a stake of 412,316 shares — an estimated $17.3M sold.
Capital Bank & Trust first reported a position in NVO in Q2 2017 and held it in 17 quarters. The position peaked at $57.1M in Q2 2017. 805 funds tracked by Wall St. Rank hold NVO as of Q3 2021.
- Capital Bank & Trust reported no remaining Novo Nordisk position as of Q3 2021 after selling out during the quarter.
- Capital Bank & Trust sold 412,316 Novo Nordisk shares in Q3 2021, an estimated $17.3M.
- Capital Bank & Trust first reported a position in Novo Nordisk in Q2 2017 and held it in 17 quarters.
- Capital Bank & Trust's Novo Nordisk position peaked at $57.1M in Q2 2017.
- 805 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2021.
Based on Capital Bank & Trust's 13F filing for Q3 2021, filed 15 Nov 2021.